4//SEC Filing
JOHNSON KENNETH ERLAND 4
Accession 0001867096-24-000016
CIK 0001867096other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:04 PM ET
Size
5.3 KB
Accession
0001867096-24-000016
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Award
Common Stock
2024-01-31+175,000→ 446,860 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
- [F2]These shares include 2,077 shares that were purchased on June 30, 2023 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743774
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:04 PM ET
- Size
- 5.3 KB